Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
Condition(s):Breast CancerLast Updated:April 3, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:April 3, 2023Completed
Condition(s):PhotobiomodulationLast Updated:August 19, 2021Completed
Condition(s):Papillary Thyroid CarcinomaLast Updated:July 14, 2017Completed
Condition(s):Ovarian CarcinomaLast Updated:October 12, 2022Recruiting
Condition(s):Glioblastoma MultiformeLast Updated:February 25, 2020Unknown status
Condition(s):Cancer ColonLast Updated:July 15, 2022Completed
Condition(s):Urinary Bladder NeoplasmLast Updated:June 23, 2022Not yet recruiting
Condition(s):Breast Cancer; Stomach Neoplasms; Salivary Gland Neoplasms; Thyroid CancerLast Updated:August 3, 2023Completed
Condition(s):Direct Pulp CappingLast Updated:February 10, 2010Terminated
Condition(s):Dental Implant FailedLast Updated:March 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.